PGI7 COST-EFFECTIVENESS OF PEGINTERFERON ALFA-2A (40KD) (PEGASYS®) COMPARED TO LAMIVUDINE AS FIRST LINE TREATMENT OF CHRONIC HEPATITIS B (CHB) IN THE UK
Abstract
Authors
PL Veenstra SD Sullivan GM Dusheiko M Jacobs GJ Lewis KK Patel